|Brand Name||Strength||Common Use||Tier Change||Clinical Edits||Prescription Drug List Tier|
|Standard Formulary||Value Formulary||Performance Formulary||Advantage Formulary||Legacy Formulary|
|ERLEADA||60mg||Treats prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone||Positive||PA||2||2||2||2||2|
|INVOKANA||100mg and 300mg||Sodium-glucose co-transporter 2 (SGLT2) inhibitor used to control blood sugar in people with type 2 diabetes mellitus, in addition to diet and exercise||Positive||2||2 (no change)||2||2 (no change)||2 (no change)|
|PICATO||0.05% and 0.015%||Gel treatment for actinic keratosis||Positive||2||2 (no change)||2||2 (no change)||2|
|SYMTUZA||800-150-200-10mg||Oral treatment to help control Human Immunodeficiency Virus-1 (HIV-1) infection||Positive||2||2||2||2||2|
|UPTRAVI||200mg, 400mg, 600mg, 800mg, 1000mg, 1200mg, 1400mg and 1600mg||Prostacyclin receptor agonist indicated for the
treatment of pulmonary arterial hypertension (PAH, WHO Group I)
|VELPHORO||500mg||Phosphate binder that helps prevent hypocalcemia (low levels of calcium in the blood) caused by elevated phosphorus||Positive||2||2 (no change)||2||2 (no change)||2|
|VIBERZI||75mg and 100mg||Treats irritable bowel syndrome with diarrhea (IBS-D)||Positive||2||2||2||2||2|
PA: Prior authorization
QL: Quantity limit
ST: Step therapy
T1/Tier 1: Generic
T2/Tier 2: Brand
T3/Tier 3: Non-preferred
NC: Not covered: This drug is not covered. However, if the covered alternative is not appropriate for the customer, there is a process where his/her provider can request approval of this drug.
Health benefit plans vary, but in general to be eligible for coverage a drug must be approved by the Food and Drug Administration (FDA), prescribed by a health care professional, purchased from a licensed pharmacy and medically necessary. Some plans require use an in-network pharmacy for prescriptions to be covered. Coverage is subject to any plan deductible, copayment and/or coinsurance requirements. Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and complete details of prescription drug coverage, contact a Cigna representative.
All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Cigna Behavioral Health, Inc., Cigna Health Management, Inc., Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.
© 2020 Cigna. All rights reserved